Lamotrigin Bluefish

Lamotrigine, the active ingredient in Lamotrigin Bluefish, is an anticonvulsant presented as an oral tablet for oral use. It treats partial seizures, generalized tonic‑clonic seizures and serves as a maintenance therapy for bipolar disorder. GNH USA supplies Lamotrigin Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is used in the management of seizure disorders and mood stabilization. Partial seizures: reduces frequency and severity of focal seizure episodes. Generalized tonic‑clonic seizures: helps prevent full‑body convulsive events. Bipolar disorder (maintenance therapy): stabilizes mood and lowers risk of depressive or manic relapse.

Lamotrigine may cause a range of adverse reactions.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Nausea or abdominal discomfort. - Blurred vision. - Insomnia or sleep disturbances. - Mild skin rash.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Severe skin reactions with blistering or peeling. - Blood dyscrasias such as agranulocytosis. - Hepatic failure or significant liver enzyme elevation.

Use lamotrigine with careful clinical monitoring. Pregnancy: Category D – potential fetal risk; prescribe only when benefits outweigh risks. Renal or hepatic impairment: dose may require adjustment; monitor organ function. Concomitant valproate: may increase lamotrigine levels; close monitoring needed. History of severe skin reactions: avoid or use with extreme caution. Avoid abrupt discontinuation: may precipitate seizure recurrence. Store at ambient temperature: keep in original container, protect from moisture and light.

Lamotrigine interacts with several drugs that affect its metabolism.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine plasma concentrations. - Carbamazepine: reduces lamotrigine levels, potentially decreasing efficacy. - Oral contraceptives: may lower lamotrigine concentrations, reducing seizure control.

Moderate Interactions (Monitor Closely): - Other enzyme inducers (phenytoin, phenobarbital): may lower lamotrigine levels. - Serotonergic agents: theoretical risk of serotonin syndrome; monitor for symptoms. - Antiepileptic polytherapy: adjust dose based on therapeutic drug monitoring.